Methylprednisolone Terminated Phase 2 Trials for Acute Exacerbation of Remitting Relapsing Multiple Sclerosis / Clinically Isolated Syndrome (CIS)

IndicationsStatusPurposePhase
TerminatedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT01039103Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS)